Cue Biopharma Inc (NASDAQ:CUE)

12.89
Delayed Data
As of Nov 26
 -0.69 / -5.08%
Today’s Change
9.65
Today|||52-Week Range
18.42
+3.04%
Year-to-Date

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Cue Biopharma Inc have a median target of 30.00, with a high estimate of 32.00 and a low estimate of 28.00. The median estimate represents a +132.74% increase from the last price of 12.89.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in Cue Biopharma Inc. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.39
Sales
$2.4M
Reporting Date
Nov 26

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -16.67%
 
 
 
 
 
 
Growthannually 10.38%
 
 
 
 

Sales

Growthquarterly -12.56%
 
 
 
 
 
 
Growthannually 239.53%
 
 
 
 
Key to the earnings and sales forecast charts.